Onassis Holdings Corp.
ONSS
Other OTC0.00
USD
+0.00
- -
CIK
0001279740
ISIN
US6822831060
CUSIP
682283106
Return %
Stock
S&P500
1Y
200.00
26.53
3Y
-99.25
76.60
5Y
-90.45
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Eliron Yaron
- Full Time Employees
- 105
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 39 Broadway New York City NY United States of America 10006
- IPO Date
- Feb 12, 2013
- CIK
- 0001279740
- Website
- onassis-holdings.com
- Similar Companies
- Business
- Onassis Holdings Corp. actively engages in the wellness and biotechnology industries, with a concentrated focus on cellular rejuvenation and advanced nutraceutical offerings. The company is committed to advancing innovative anti-aging technologies, specifically through epigenetic reprogramming, and distributing a portfolio of meticulously researched dietary supplements. Furthermore, it supplies cannabidiol (CBD) and hemp oil products to markets spanning the United States and Europe. Recent strategic developments include initiating a substantial Regulation A+ financing round to fuel expansion and the acquisition of key nutraceutical entities. The firm has also appointed an advisory board member to oversee its international legal and trade strategies. Headquartered in New York, New York, Onassis Holdings Corp. adopted its current name in September 2019, transitioning from its former identity as Onassis Mining Group, Inc.
Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade
Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO)
Onassis Enters Agreement for International Shares Distribution